×

or

The FDC Ban – What could one expect from the DTAB Constituted Sub-Committee?

The FDC Ban – What could one expect from the DTAB Constituted Sub-Committee?

This content is restricted to premium members only.

About Author

Krishna Venkat

Krishna Venkat is a Corporate/M&A lawyer with 15 years of experience in handling cross border M&As for leading Indian conglomerates and foreign MNCs. He currently heads the FMCG, Pharmaceutical and healthcare vertical at Anoma Legal. He advises pharmaceutical and healthcare companies on a range of legal/regulatory issues that affect companies in these industries.